Cardiovascular Collapse Associated with Beta Blockade in Thyroid Storm

Abstract

We describe three cases of thyroid storm who developed sudden cardiorespiratory arrest soon after the administration of propranolol orally.

Case 1: A 43 years old Chinese lady presented with complaints of fever and chills. She had a urinary tract infection and also had signs of overt thyrotoxicosis. She was diagnosed to have thyroid storm and was started on oral propranolol, carbimazole and intravenous hydrocortisone and ceftriaxone. Soon after propranolol was given orally she developed an asystolic cardiorespiratory arrest.

Case 2: A 72 years old Chinese gentleman presented with confusion, fever and rapid atrial fibrillation. He was diagnosed to have thyroid storm and was started on oral propranolol, carbimazole and intravenous hydrocortisone and ceftriaxone. He developed a cardiorespiratory arrest about 6 hours after commencement of therapy.

Case 3: A 48-year-old Chinese gentleman presented with complains of dyspnoea and palpitations. He was diagnosed to have thyroid storm and was started on oral propranolol, carbimazole, intravenous hydrocortisone and antibiotics. About 12 hours after admission, he developed a cardiorespiratory arrest. All three patients developed cardiorespiratory arrest soon after the administration of propranolol orally. We conclude that in selective patients who have low output cardiac failure in association with severe thyrotoxicosis, it maybe advisable to avoid use of a beta blocker. A safer alternative is the use of ultra short-acting beta-blockers, such as intravenous esmolol, with extreme caution.

Thyrotoxicosis - thyrocardiac disease - dilated cardiomyopathy - adrenergic beta-antagonists - heart arrest

References

• 1 Ashikaga H, Abreu R, Schneider R.. Propranolol administration in a patient with thyroid storm.  Ann Intern Med. 2000;  132 681-682
• 2 Boccalandro C, Boccalandro F, Orlander P, Wei CP.. Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of literature.  Endocr Pract. 2003;  9 140-146
• 3 Brent GA. The molecular basis of thyroid hormone action.  N Engl J Med. 1994;  331 847-853
• 4 Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm.  Endocrinol Metab Clin North Am. 1993;  22 263-277
• 5 Davis PJ, Davis FB. Nongenomic actions of thyroid hormone.  Thyroid. 1996;  6 497-504
• 6 DeGroot WJ, Leonard JJ. Hyperthyroidism as a high cardiac output state.  Am Heart J. 1970;  79 265-275
• 7 Fadel BM, Ellahham S, Ringel MD, Lindsay Jr J, Wartofsky L, Burman KD. Hyperthyroid heart disease.  Clin Cardiol. 2000;  23 402-408
• 8 Fraser T, Green D.. Weathering the Storm: Beta-blockade and the potential for disaster in severe hyperthyroidism.  Emerg Med (Fremantle). 2001;  13 376-380
• 9 Isley W, Dahl S, Gibbs H. Use of esmolol in managing a thyrotoxic patient needing emergency surgery.  Am J Med. 1990;  89 122-123
• 10 Kahaly GJ, Wagner S, Nieswandt J, Mohr-Kahaly S, Ryan TJ.. Stress echocardiography in hyperthyroidism.  J Clin Endocrinol Metab. 1999;  84 2308-2313
• 11 Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system.  N Engl J Med. 2001;  344 501-509
• 12 Koshiyama H, Selliti DF, Akamizu T. et al . Cardiomyopathy associated with Graves’ disease.  Clin Endocrinol (Oxf). 1996;  45 111-116
• 13 Magner JA, Clark W, Allenby P. Congestive heart failure and sudden death in a young patient with thyrotoxicosis.  West J Med. 1988;  149 86-90
• 14 Merillon JP, Passa P, Chastre J, Wolf A, Gourgon R. Left ventricular function and hyperthyroidism.  Br Heart J. 1981;  46 137-143
• 15 Reilly C, Wood M, Koshakji R, Wood A. Ultrashort acting beta-blockade: a comparison with conventional betablockade.  Clin Pharmacol Ther. 1985;  38 579-585
• 16 Thorne A, Bedford R. Esmolol for perioperative management of thyrotoxic goitre.  Anesthesiology. 1989;  1 291-294
• 17 Vijayakumar H, Thomas W, Ferrara J. Perioperative management of severe thyrotoxicosis with esmolol.  Anaesthesia. 1989;  44 406-408

Correspondence